The proposed bill establishes a wholesale prescription drug importation program in Michigan, aimed at allowing licensed drug wholesalers to import prescription drugs from Canadian suppliers. The program, referred to as the "prescription drug importation act," mandates that the Department of Health and Human Services develop the program in consultation with stakeholders and federal officials. Key requirements include compliance with federal safety and cost-saving regulations, ensuring that only drugs meeting U.S. FDA standards are imported, and that the program does not violate federal patent laws. Additionally, the program must focus on importing drugs that significantly reduce costs for consumers and ensure proper tracking and tracing of imported drugs.

Before implementation, the department must seek certification from the U.S. Department of Health and Human Services and develop a registration process for participating health insurers, pharmacies, and healthcare providers. The bill also requires the department to prepare and publish an annual report detailing the program's operations, including the drugs imported, participation rates, and estimated cost savings. Furthermore, the department is tasked with monitoring potential anticompetitive behavior in the industry and has the authority to promulgate rules necessary for the program's implementation.